Aeolus Pharmaceuticals (AOLS)

[GetSeriousOK]

Nice find! No 8k filed by Aeolus -- odd.

I guess we won't know how much Aeolus got until they file the 10-K or perhaps even the 10-Q for Oct-Dec 2017. Probably wasn't much, based on the next paragraph in the 10-Q:

ARCA biopharma, Inc. is developing bucindolol under the trade name Gencaro as a beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado. The future development of Gencaro is uncertain. In the event that Gencaro is approved for sale, however, we may be owed royalties on sales. There can be no guarantees, however, that Gencaro will ever be approved or sold or achieve sufficient revenues to generate royalties.